Deferred autologous stem cell transplantation in systemic AL amyloidosis

High-dose melphalan with autologous stem cell transplantation (ASCT) can induce durable haematological and organ responses in systemic AL amyloidosis (AL). Stringent selection criteria have improved safety of ASCT in AL but most patients are transplant-ineligible. We report our experience of deferre...

Descripción completa

Detalles Bibliográficos
Autores principales: Manwani, Richa, Hegenbart, Ute, Mahmood, Shameem, Sachchithanantham, Sajitha, Kyriakou, Charalampia, Yong, Kwee, Popat, Rakesh, Rabin, Neil, Whelan, Carol, Dittrich, Tobias, Kimmich, Christoph, Hawkins, Philip, Schönland, Stefan, Wechalekar, Ashutosh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6218452/
https://www.ncbi.nlm.nih.gov/pubmed/30397193
http://dx.doi.org/10.1038/s41408-018-0137-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6218452/
https://www.ncbi.nlm.nih.gov/pubmed/30397193
http://dx.doi.org/10.1038/s41408-018-0137-9

Ejemplares similares